Skip to content
value.today

Myocardial Solutions, Inc.

Total raised
$30 M
5 rounds on record
Latest round
$3 M
Jun 2023
First round on record
Jun 2016
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Myocardial Solutions, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2023$3 MNo. 5$2 to $10 million

Myocardial Solutions, Inc.: Raise no. 5, Jun 2023

Investors in this round

43 investors had bought by the notice of Jun 30, 2023: 43 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert L. Kay · Executive Officer, Director
  • Dane A. Andreeff · Director
  • Gary R. Brock · Director
  • Nelson R. Hill · Director
  • Todd A. Robinson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering”

Signed by Robert L. Kay, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 30, 2023. Read the notice at the SEC.

debt, optionsSEC
Mar 2021$11 MNo. 4$10 to $50 million

Myocardial Solutions, Inc.: Raise no. 4, Mar 2021

Investors in this round

33 investors had bought by the notice of Mar 23, 2021: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $15 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Denise P. McKenzie · Executive Officer
  • John P. Funkhouser · Executive Officer, Director
  • Dane P. Andreeff · Director
  • Randy P. Hill · Director
  • Todd P. Robinson · Director
  • William P. Burke · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering”

Signed by Denise McKenzie, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 23, 2021. Read the notice at the SEC.

equitySEC
Dec 2018$7 MNo. 3$2 to $10 million

Myocardial Solutions, Inc.: Raise no. 3, Dec 2018

Investors in this round

26 investors had bought by the notice of Mar 6, 2019: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Denise A. McKenzie · Executive Officer
  • John P. Funkhouser · Executive Officer, Director
  • Nael A. Osman · Executive Officer
  • Dane A. Andreeff · Director
  • Randy A. Hill · Director
  • Todd A. Robinson · Director
  • William A. Burke · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering.”

Signed by John P. Funkhouser, President. Source: SEC Form D and 2 amendments, newest notice filed Mar 6, 2019. Read the notice at the SEC.

equitySEC
Jun 2017$5 MNo. 2$2 to $10 million

Myocardial Solutions, Inc.: Raise no. 2, Jun 2017

Investors in this round

37 investors had bought by the notice of Jul 7, 2017: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Denise P. McKenzie · Executive Officer
  • John P. Funkhouser · Executive Officer, Director
  • Nael P. Osman · Executive Officer
  • Dane P. Andreeff · Director
  • Randy P. Hill · Director
  • Timothy P. McLaughlin · Director
  • William P. Burke · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering.”

Signed by John P. Funkhouser, President. Source: SEC Form D, newest notice filed Jul 7, 2017. Read the notice at the SEC.

equitySEC
Jun 2016$4 MNo. 1$2 to $10 million

Myocardial Solutions, Inc.: Raise no. 1, Jun 2016

Investors in this round

29 investors had bought by the notice of Jun 15, 2016: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Denise P. McKenzie · Executive Officer
  • John P. Funkhouser · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering.”

Signed by Denise McKenzie, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 15, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Myocardial Solutions, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2023).

    SEC Form D · Jun 2023

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2023

That is all the official record says: Myocardial Solutions, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Myocardial Solutions, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 43 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Myocardial Solutions, Inc.
NameRoleNamed in
Robert L. KayExecutive officerJun 2023
Denise P. McKenzieExecutive officerMar 2021
John P. FunkhouserExecutive officerMar 2021
Denise A. McKenzieExecutive officerMar 2019
Nael A. OsmanExecutive officerMar 2019
Nael P. OsmanExecutive officerJul 2017
Dane A. AndreeffDirectorJun 2023
Gary R. BrockDirectorJun 2023
Nelson R. HillDirectorJun 2023
Robert L. KayDirectorJun 2023
Todd A. RobinsonDirectorJun 2023
Dane P. AndreeffDirectorMar 2021
John P. FunkhouserDirectorMar 2021
Randy P. HillDirectorMar 2021
Todd P. RobinsonDirectorMar 2021
William P. BurkeDirectorMar 2021
Randy A. HillDirectorMar 2019
William A. BurkeDirectorMar 2019
Timothy P. McLaughlinDirectorJul 2017